These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3741480)

  • 1. Effect of deuterium substitution on the disposition of intraperitoneal tryptamine.
    Dyck LE; Boulton AA
    Biochem Pharmacol; 1986 Sep; 35(17):2893-6. PubMed ID: 3741480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of deuterium substitution on the catabolism of beta-phenylethylamine: an in vivo study.
    Dyck LE; Durden DA; Boulton AA
    J Neurochem; 1986 Feb; 46(2):399-404. PubMed ID: 3941313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues.
    Yu PH; Bailey BA; Durden DA; Boulton AA
    Biochem Pharmacol; 1986 Mar; 35(6):1027-36. PubMed ID: 3954792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of intraventricularly injected trace amines and their deuterated isotopomers.
    Durden DA; Nguyen TV; Boulton AA
    Neurochem Res; 1988 Oct; 13(10):943-50. PubMed ID: 3216952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative contribution of monoamine oxidase and cytochrome p450 isozymes to the metabolic deamination of the trace amine tryptamine.
    Yu AM; Granvil CP; Haining RL; Krausz KW; Corchero J; Küpfer A; Idle JR; Gonzalez FJ
    J Pharmacol Exp Ther; 2003 Feb; 304(2):539-46. PubMed ID: 12538805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deuterium isotope effects on the enzymatic oxidative deamination of trace amines.
    Yu PH; Barclay S; Davis B; Boulton AA
    Biochem Pharmacol; 1981 Nov; 30(22):3089-94. PubMed ID: 7337725
    [No Abstract]   [Full Text] [Related]  

  • 7. Isotope effects in the enzymatic oxidation of tryptamine to 3-indolyl-acetaldehyde.
    Dragulska S; Winnicka E; Kańska M
    Isotopes Environ Health Stud; 2014 Jun; 50(2):269-76. PubMed ID: 24438014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect.
    Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
    Biochem Pharmacol; 1982 Aug; 31(15):2513-6. PubMed ID: 6812592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A sensitive method of determining monoamine oxidase activity in tissue by measurement of aldehyde semicarbazone].
    Popov N; Rösler V; Thiemann C; Matthies H
    Acta Biol Med Ger; 1971; 26(2):239-45. PubMed ID: 5142861
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of alpha-alkylated tryptamine derivatives on 5-hydroxytryptamine metabolism in vivo.
    GEY KF; PLETSCHER A
    Br J Pharmacol Chemother; 1962 Aug; 19(1):161-7. PubMed ID: 13898151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 14. Ontogenesis of enzyme systems deaminating different monoamines.
    Blatchford D; Holzbauer M
    Br J Pharmacol; 1976 Jun; 57(2):279-93. PubMed ID: 938797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo metabolism of alpha,alpha,beta,beta-tetradeutero-N, N-dimethyltryptamine in rodent brain.
    Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
    Biochem Pharmacol; 1984 May; 33(9):1395-400. PubMed ID: 6587850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of oxidative deamination of biogenic amines in the myocardium in experimental atherosclerosis].
    Brusova EG; Krivchenkova RS
    Vopr Med Khim; 1979; 25(2):198-204. PubMed ID: 442591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate-limiting step in the metabolism of polar and non-polar monoamines in lung and liver.
    Ben-Harari RR; Peleg R; Youdim MB
    Br J Pharmacol; 1982 May; 76(1):77-83. PubMed ID: 6805544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of a beta-carboline (1,2,3,4-tetrahydro-1-methyl-beta-carboline-1-carboxylic acid) following intracerebroventricular injection of tryptamine and pyruvic acid.
    Susilo R; Rommelspacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):70-6. PubMed ID: 3574494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues.
    Sullivan JP; McDonnell L; Hardiman OM; Farrell MA; Phillips JP; Tipton KF
    Biochem Pharmacol; 1986 Oct; 35(19):3255-60. PubMed ID: 3094536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of 4-methoxyphenethylamine derivatives as inhibitors of monoamine oxidase.
    Keller WJ; Ferguson GG
    J Pharm Sci; 1976 Oct; 65(10):1539-40. PubMed ID: 978418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.